Carina Bethlehem

Dr. Carina Bethlehem

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2025 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
CHChristoph Hüser
Christoph Hüser
CBCarina Bethlehem
Carina Bethlehem
MDMartin W. Dünser
Martin W. Dünser
CGCornelia Genbrugge
Cornelia Genbrugge
MGMarc Ghannoum
Marc Ghannoum
Bruno MégarbaneBruno Mégarbane
Bruno Mégarbane

4 January 2021 in Critical Care Research and Practice
Verified
Journal Article
Open access
PDF file
EBE. Christiaan Boerma
E. Christiaan Boerma
CBCarina Bethlehem
Carina Bethlehem
FSFranciena Stellingwerf
Franciena Stellingwerf
FLFellery de Lange
Fellery de Lange
KSKoen W. Streng
Koen W. Streng
IBInge T. Bootsma
Inge T. Bootsma
Background. Solid data on cardiovascular derangements in critically ill COVID-19 patients remain scarce. The aim of this study is to describe hemodynamic characteristics in a cohort of COVID-19-related critically ill patients. Methods. A retrospective observational cohort study in twenty-eight consecutive mechanically ventilated COVID-19 patients. Pulse contour analysis-derived data were obtained from all patients, using the PiCCO® system. Results. The mean arterial pressure increased from 77 ± 10 mmHg on day 1 to 84 ± 9 mmHg on day 21 ( ), in combination with the rapid tapering and cessation of norepinephrine and the gradual use of antihypertensive drugs in the vast majority of patients. The cardiac index increased significantly from 2.8 ± 0.7 L/min/m2 on day 1 to 4.0 ± 0.8 L/min/m2 on day 21 ( ). Dobutamine was administered in only two patients. Mean markers of left ventricular contractility and peripheral perfusion, as well as lactate levels, remained within the normal range. Despite a constant fluid balance, extravascular lung water index decreased significantly from 17 ± 7 mL/kg on day 1 to 11 ± 4 mL/kg on day 21 ( ). Simultaneously, intrapulmonary right-to-left shunt fraction (Qs/Qt) decreased significantly from 27 ± 10% in week 1 to 15 ± 9% in week 3 ( ). PaO2/FiO2 ratio improved from 159 ± 53 mmHg to 319 ± 53 mmHg ( ), but static lung compliance remained unchanged. Conclusions. In general, this cohort of patients with COVID-19 respiratory failure showed a marked rise in blood pressure over time, not accompanied by distinctive markers of circulatory failure. Characteristically, increased extravascular lung water, vascular permeability, and intrapulmonary shunt diminished over time, concomitant with an improvement in gas exchange.

26 August 2022 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
LBLaura Buisman
Laura Buisman
IRIneke J. Riphagen
Ineke J. Riphagen
MKMarieke Kwant
Marieke Kwant
MTMargo D. Themmen
Margo D. Themmen
MBMarjan Bouma
Marjan Bouma
CBCarina Bethlehem
Carina Bethlehem

1 November 2025 in Viruses
Verified
Journal Article
Open access
PDF file
SBSjoerd van der Bie
Sjoerd van der Bie
JAJohannes P. C. van Den Akker
Johannes P. C. van Den Akker
RFRamon Fluit
Ramon Fluit
SLSteven van Lelyveld
Steven van Lelyveld
MNMaarten E. Nuver
Maarten E. Nuver
MGMarco Goeijenbier
Marco Goeijenbier
Background: Influenza can cause severe complications, especially in patients with specific risk factors or comorbidities associated with poor outcomes. Some patients are at increased risk of a complicated disease course, including secondary infections, ICU admission, and the need for mechanical ventilation. The first post–COVID-19 seasonal influenza season placed a substantial burden on Dutch ICUs. This study investigates the disease course and outcomes of ICU patients with influenza. Methods: A retrospective influenza registry study was conducted across 34 Dutch ICUs, including patients aged 18 and older admitted to the ICU with a positive influenza RT-PCR test, between 1 November 2023 and 17 March 2024. Data on demographic information, medical history, clinical symptoms, laboratory and imaging results, parameters of mechanical ventilation, additional treatments, length of hospital stay, and mortality was retrieved from the electronic patient record. Results: A total of 498 patients were included in the study. The median age was 64 (IQR: 55–72) years and 58.8% of the patients were men. The most common comorbidities were cardiovascular disease (34.1%), chronic obstructive pulmonary disease (COPD) (31.5%), and diabetes (22.3%). Bacterial co-infections were present in 37.6% of the patients. Invasive mechanical ventilation (IMV) was necessary in 46.0% of patients, 38.0% of those requiring IMV were treated in prone position. A substantial mortality rate was observed, with an ICU mortality rate of 21.9% and an additional hospital mortality rate of 5.2%. Conclusion: This study described the characteristics and course of disease of all patients with laboratory-confirmed influenza infection admitted to one of the 34 participating Dutch ICUs between November 2023 and March 2024. The major findings of this study are the substantial mortality rate, a high proportion of patients with bacterial co-infections, and a significant percentage of patients requiring IMV and prone position ventilation. Finally, patients without comorbidities that were admitted to the ICU with an influenza virus infection showed severe disease parameters but had a lower mortality than patients with comorbidities.

27 September 2024 in European Journal of Hospital Pharmacy
Verified
Journal Article
Closed access
PDF file
MPMatthijs Plas
Matthijs Plas
LKLinda M Kampschreur
Linda M Kampschreur
JKJohannes A Kroes
Johannes A Kroes
LPLeendert Porcelijn
Leendert Porcelijn
CBCarina Bethlehem
Carina Bethlehem
We present a case of drug-induced immune thrombocytopenia (DITP) proven to be due to ceftriaxone instead of assumed tuberculostatic treatment in a patient with miliary tuberculosis. It is important to identify the culprit drug in DITP to avoid discontinuing essential treatment, especially when more than one drug is implicated. In these cases additional analysis (drug-dependent platelet antibody testing) should be considered to prevent unnecessary replacement of a first-line regimen of tuberculostatic treatment with an alternative treatment regime.

24 February 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
CBCarina Bethlehem
Carina Bethlehem
IBInge T Bootsma
Inge T Bootsma
FLFellery De Lange
Fellery De Lange
EBE Christiaan Boerma
E Christiaan Boerma
Objectives Impaired right ventricular (RV) function after cardiac surgery is associated with morbidity and long-term mortality. The purpose of this study was to identify factors that play a role in the development of RV dysfunction in the perioperative cardiac surgery setting. Design We performed a prospective, observational, single centre study. Over a 2-year period, baseline and perioperative characteristics were recorded. For analysis, subjects were divided into three groups: patients with a ≥3% absolute increase in postoperative RV ejection fraction (RVEF) in comparison to baseline (RVEF+), patients with a ≥3% absolute decrease in RVEF (RVEF−) and patients with a <3% absolute change in RVEF (RVEF=). Setting Tertiary care hospital in the Netherlands. Participants We included all cardiac surgery patients ≥18 years of age equipped with a pulmonary artery catheter and admitted to the ICU in 2015–2016. There were no exclusion criteria. A total number of 267 patients were included (65.5% men). Outcome measures Risk factors for a perioperative decline in RV function. Results A reduction in RVEF was observed in 40% of patients. In multivariate analysis, patients with RVEF− were compared with patients with RVEF= (first-mentioned OR) and RVEF+ (second-mentioned OR). Preoperative use of calcium channel blocker (CCB) (OR 3.06, 95% CI 1.24 to 7.54/OR 2.73, 95% CI 1.21 to 6.16 (both p=0.015)), intraoperative fluid balance (FB) (OR 1.45, 95% CI 1.02 to 2.06 (p=0.039)/OR 1.09, 95% CI 0.80 to 1.49 (p=0.575)) and baseline RVEF (OR 1.22; 95% CI 1.14 to 1.30/OR 1.27, 95% CI 1.19 to 1.35 (both p<0.001)) were identified as independent risk factors for a decline in RVEF during surgery. Conclusion Apart from the impact of the perioperative FB, preoperative use of a CCB as a risk factor for perioperative reduction in RVEF is the most prominent new finding of this study.